Net profit of Lincoln Pharmaceuticals declined 4.77% to Rs 26.33 crore in the quarter ended September 2024 as against Rs 27.65 crore during the previous quarter ended September 2023. Sales rose 3.35% to Rs 161.21 crore in the quarter ended September 2024 as against Rs 155.99 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales161.21155.99 3 OPM %17.6019.97 - PBDT38.0139.45 -4 PBT34.7836.87 -6 NP26.3327.65 -5 Powered by Capital Market - Live News

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 as against Rs 19.01 crore during the previous quarter ended June 2023. Sales rose 8.60% to Rs 147.28 crore in the quarter ended June 2024 as against Rs 135.62 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales147.28135.62 9 OPM %15.4315.28 - PBDT32.7027.99 17 PBT29.4825.45 16 NP23.6719.01 25 Powered by Capital Market - Live News